Ming Lin

1.7k total citations
51 papers, 1.3k citations indexed

About

Ming Lin is a scholar working on Molecular Biology, Oncology and Statistics and Probability. According to data from OpenAlex, Ming Lin has authored 51 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Statistics and Probability. Recurrent topics in Ming Lin's work include Ubiquitin and proteasome pathways (9 papers), Statistical Methods and Inference (6 papers) and Glycosylation and Glycoproteins Research (4 papers). Ming Lin is often cited by papers focused on Ubiquitin and proteasome pathways (9 papers), Statistical Methods and Inference (6 papers) and Glycosylation and Glycoproteins Research (4 papers). Ming Lin collaborates with scholars based in China, United States and Taiwan. Ming Lin's co-authors include Keith G. Danielson, Edward I. Ginns, Zhantao Yang, Paul Börnstein, Themis R. Kyriakides, Steven D. Bain, Cindy E. McKinney, Renato V. Iozzo, Lynne T. Smith and Mary E. LaMarca and has published in prestigious journals such as Nucleic Acids Research, The Journal of Chemical Physics and The Journal of Cell Biology.

In The Last Decade

Ming Lin

47 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ming Lin China 20 778 235 217 137 125 51 1.3k
Harvey H. Hensley United States 21 628 0.8× 305 1.3× 173 0.8× 175 1.3× 71 0.6× 41 1.2k
Patrick R. Blackburn United States 19 923 1.2× 250 1.1× 235 1.1× 328 2.4× 151 1.2× 74 1.7k
A Peng China 9 896 1.2× 338 1.4× 330 1.5× 64 0.5× 72 0.6× 12 1.4k
Dorina Gui United States 23 862 1.1× 345 1.5× 243 1.1× 93 0.7× 75 0.6× 52 1.7k
Tim H. Brümmendorf Germany 22 753 1.0× 325 1.4× 195 0.9× 95 0.7× 84 0.7× 86 1.6k
Ichiro Maeda Japan 21 772 1.0× 355 1.5× 300 1.4× 284 2.1× 59 0.5× 80 1.6k
Atsushi Niida Japan 18 1.0k 1.3× 361 1.5× 387 1.8× 155 1.1× 90 0.7× 42 1.5k
Paul Elvin United Kingdom 20 732 0.9× 391 1.7× 230 1.1× 114 0.8× 112 0.9× 47 1.3k
Ute Pohl United Kingdom 16 808 1.0× 174 0.7× 288 1.3× 54 0.4× 96 0.8× 35 1.5k
Sara A. Byron United States 18 1.3k 1.7× 375 1.6× 549 2.5× 161 1.2× 117 0.9× 48 1.9k

Countries citing papers authored by Ming Lin

Since Specialization
Citations

This map shows the geographic impact of Ming Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Lin more than expected).

Fields of papers citing papers by Ming Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Lin. The network helps show where Ming Lin may publish in the future.

Co-authorship network of co-authors of Ming Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Ming Lin. A scholar is included among the top collaborators of Ming Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming Lin. Ming Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zheng, Minghao, et al.. (2024). ACAT1 suppresses clear cell renal cell carcinoma progression by AMPK mediated fatty acid metabolism. Translational Oncology. 47. 102043–102043. 2 indexed citations
3.
Cai, Zongwu, et al.. (2024). A NONPARAMETRIC TEST OF HETEROGENEITY IN CONDITIONAL QUANTILE TREATMENT EFFECTS. Econometric Theory. 41(3). 660–687.
4.
5.
Xin, Ying, Jiayu Liu, Sifei Yu, et al.. (2023). Abstract 2256: Cancer stem cells and exosomal PD-L1 suppress anti-tumor B cells. Cancer Research. 83(7_Supplement). 2256–2256. 1 indexed citations
6.
Ruan, Shasha, Ming Lin, Lawrence G. Lum, et al.. (2019). Integrin β4–Targeted Cancer Immunotherapies Inhibit Tumor Growth and Decrease Metastasis. Cancer Research. 80(4). 771–783. 60 indexed citations
7.
Zhu, Yanli, Haiqiang Chen, & Ming Lin. (2018). Threshold models with time-varying threshold values and their application in estimating regime-sensitive Taylor rules. Studies in Nonlinear Dynamics and Econometrics. 23(5). 6 indexed citations
8.
Li, Qiao, et al.. (2017). Development and Application of Cancer Stem Cell-Targeted Vaccine in Cancer Immunotherapy. Journal of Vaccines & Vaccination. 8(6). 11 indexed citations
9.
Wang, Xiaozhen, Guang Lu, Li Li, et al.. (2014). HUWE1 interacts with BRCA1 and promotes its degradation in the ubiquitin–proteasome pathway. Biochemical and Biophysical Research Communications. 444(4). 549–554. 32 indexed citations
10.
Wang, Xiaozhen, Guang Lu, Li Li, et al.. (2013). HUWE1 interacts with BRCA1 and promotes its degradation in the ubiquitin–proteasome pathway. Biochemical and Biophysical Research Communications. 444(3). 290–295. 57 indexed citations
11.
Yang, Hua, Ming Lin, Fuxia Xiong, et al.. (2011). Combined lysosomal protein transmembrane 4 beta-35 and argininosuccinate synthetase expression predicts clinical outcome in hepatocellular carcinoma patients. Surgery Today. 41(6). 810–817. 15 indexed citations
12.
Meng, Fanling, Yuanlong Hu, Mingzhu Yin, et al.. (2010). Overexpression of LAPTM4B-35 in Cervical Carcinoma. International Journal of Gynecological Pathology. 29(6). 587–593. 24 indexed citations
13.
Zhang, Jian, Joseph Dundas, Ming Lin, et al.. (2009). Prediction of geometrically feasible three-dimensional structures of pseudoknotted RNA through free energy estimation. RNA. 15(12). 2248–2263. 42 indexed citations
14.
Yang, Hua, et al.. (2009). LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology. 136(2). 275–281. 59 indexed citations
15.
16.
Nabhan, Chadi, Jacob D. Bitran, Michael D. Taylor, et al.. (2007). Patterns of Care in Follicular Lymphoma (FL): Are Minorities Being Treated Differently? Report from the National LymphoCare Study (NLCS).. Blood. 110(11). 367–367. 3 indexed citations
17.
Zhang, Jinfeng, Ming Lin, Rong Chen, Jie Liang, & Jun S. Liu. (2006). Monte Carlo sampling of near‐native structures of proteins with applications. Proteins Structure Function and Bioinformatics. 66(1). 61–68. 20 indexed citations
18.
Lin, Ming, et al.. (2002). THE SMALL SAMPLE PROPERTIES OF THE PRINCIPAL COMPONENTS ESTIMATOR FOR REGRESSION COEFFICIENTS. Communication in Statistics- Theory and Methods. 31(2). 271–283. 4 indexed citations
19.
Lin, Ming, et al.. (2000). Smoking among ethnic Chinese patients and their recall of quit advice by Chinese-speaking general practitioners in Sydney. Australian and New Zealand Journal of Public Health. 24(4). 437–440. 6 indexed citations
20.
Hsu, Chiun, et al.. (1997). MVP (mitomycin-C, vinblastine, cisplatin) salvage chemotherapy for relapsed and refractory metastatic breast cancer.. PubMed. 96(3). 185–8. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Harvey H. Hensley Breakdown of academic impact, for papers by Patrick R. Blackburn Breakdown of academic impact, for papers by A Peng Breakdown of academic impact, for papers by Dorina Gui Breakdown of academic impact, for papers by Tim H. Brümmendorf Breakdown of academic impact, for papers by Ichiro Maeda Breakdown of academic impact, for papers by Atsushi Niida Breakdown of academic impact, for papers by Paul Elvin Breakdown of academic impact, for papers by Ute Pohl Breakdown of academic impact, for papers by Sara A. Byron
Rankless by CCL
2026